Your browser doesn't support javascript.
loading
[Translated article] Adjusted indirect comparison of zanubrutinib and ibrutinib in first-line treatment of chronic lymphocytic leukemia.
Salmerón-Navas, Francisco Javier; Barreiro-Fernández, Ester María; Fénix-Caballero, Silvia.
Affiliation
  • Salmerón-Navas FJ; Unidad de Gestión Clínica de Farmacia, Hospital Comarcal Valle de los Pedroches, Pozoblanco, Córdoba, Spain. Electronic address: csalnav@gmail.com.
  • Barreiro-Fernández EM; Unidad de Gestión Clínica de Farmacia, Hospital San Juan de la Cruz, Úbeda, Jaén, Spain.
  • Fénix-Caballero S; Unidad de Gestión Clínica de Farmacia, Hospital Universitario de Puerto Real, Puerto Real, Cádiz, Spain.
Farm Hosp ; 48(1): T9-T15, 2024.
Article in En, Es | MEDLINE | ID: mdl-37845105
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell Limits: Humans Language: En / Es Journal: Farm Hosp Journal subject: FARMACIA / HOSPITAIS Year: 2024 Document type: Article Country of publication: Spain
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell Limits: Humans Language: En / Es Journal: Farm Hosp Journal subject: FARMACIA / HOSPITAIS Year: 2024 Document type: Article Country of publication: Spain